Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease-Reference-Cited by-同舟云学术

Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease

Published:2017-09-20 Issue:6 Volume:4 Page:829-837
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Standaert David G.¹^ORCID,Rodriguez Ramon L.²,Slevin John T.³,Lobatz Michael⁴,Eaton Susan⁵,Chatamra Krai⁵,Facheris Maurizio F.⁵,Hall Coleen⁵,Sail Kavita⁵,Jalundhwala Yash J.⁵,Benesh Janet⁵

Affiliation:

1. University of Alabama at Birmingham; Birmingham Alabama USA

2. University of Central Florida; Orlando FL USA

3. University of Kentucky Medical Center; Lexington KY USA

4. Neurology Center of Southern California; CA USA

5. AbbVie Inc.; North Chicago IL USA

Funder

AbbVie

American Parkinson's Disease Foundation

Parkinson Research Foundation

Alabama Department of Commerce

National Institutes of Health

Allergan

Auspex

Biotie Therapeutics

Dystonia Coalition

Huntington Study Group

Ipsen Fund

Merz Pharmaceuticals

National Parkinson Foundation

Parkinson's Study Group

Chelsea

Veterans Administration

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mdc3.12526/fullpdf

Reference27 articles.

1. Frequency of levodopa- related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov Disord,2001

2. Oral and infusion levodopa- based strategies for managing motor complications in patients with Parkinson's disease;Antonini;CNS Drugs,2010

3. Late-stage Parkinson's disease;Coelho;Nat Rev Neurol,2012

4. Pharmacokinetics of levodopa;Contin;J Neurol,2010

5. Gastric emptying time and gastric motility in patients with Parkinson's disease;Hardoff;Mov Disord,2001

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Artificial Neural Network Predicts Gender Differences of Motor and Non-Motor Symptoms of Patients with Advanced Parkinson’s Disease under Levodopa–Carbidopa Intestinal Gel;Medicina;2024-05-26

2. Levodopa infusion therapies for Parkinson disease;Current Opinion in Neurology;2024-05-23

3. Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience;Pharmaceutics;2024-03-25

4. Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson’s disease patients;Scientific Reports;2024-02-14

5. Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study;Neurology and Therapy;2024-02-12